Enavate Sciences GP, LLC Long-Term Concentrated

CIK: 0001953107 · Show all filings

Period: Q2 2025 (← Previous) (Next →)

Filing Date: Aug 14, 2025

Total Value ($000): $176,535 (100.0% shares, 0.0% debt)

Holdings (6)

IMNM IMMUNOME INC 25.1%

Value ($000) $44,348 Shares 4,768,583 Est. Cost $11.41 Unrealized -28.1%

SION SIONNA THERAPEUTICS INC 24.4%

Value ($000) $42,994 Shares 2,478,030 Est. Cost $16.34 Unrealized -19.8%

ZBIO ZENAS BIOPHARMA INC 20.6%

Value ($000) $36,448 Shares 3,761,359 Est. Cost $15.60 Unrealized -37.6%

UPB UPSTREAM BIO INC 15.3%

Value ($000) $27,008 Shares 2,459,703 Est. Cost $22.33 Unrealized -58.6%

CMPX COMPASS THERAPEUTICS INC 11.5%

Value ($000) $20,249 Shares 7,788,150 Est. Cost $1.66 Unrealized +24.2%

CAMP CAMP4 THERAPEUTICS CORP 3.1%

Value ($000) $5,489 Shares 3,785,802 Est. Cost $8.22 Unrealized -75.8%

Ticker	Issuer	Shares	Value ($000)	%	Est. Cost	Unrealized	Class	CUSIP
IMNM	IMMUNOME INC	4,768,583	$44,348	25.1%	$11.41	-28.1%	COM	45257U108
SION	SIONNA THERAPEUTICS INC	2,478,030	$42,994	24.4%	$16.34	-19.8%	COM	829401108
ZBIO	ZENAS BIOPHARMA INC	3,761,359	$36,448	20.6%	$15.60	-37.6%	COM	98937L105
UPB	UPSTREAM BIO INC	2,459,703	$27,008	15.3%	$22.33	-58.6%	COM	91678A107
CMPX	COMPASS THERAPEUTICS INC	7,788,150	$20,249	11.5%	$1.66	+24.2%	COM	20454B104
CAMP	CAMP4 THERAPEUTICS CORP	3,785,802	$5,489	3.1%	$8.22	-75.8%	COM	13463J101